Decreased serotonergic responsivity in platelets of drug-free patients with schizophrenia

Psychiatry Research

Volumn 63, Issue 2-3, 1996, Pages 123-132

  Yao, Jeffrey K ^a,b   Van Kammen, Daniel P ^a,b   Moss, Howard B ^b   Sokulski, David E ^b  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

5 Hydroxytryptamine; Dense granule secretion; Haloperidol

Indexed keywords

ADENOSINE DIPHOSPHATE; HALOPERIDOL; NEUROLEPTIC AGENT; SEROTONIN;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG WITHDRAWAL; HUMAN; PREDICTION; PRIORITY JOURNAL; SCHIZOPHRENIA; THROMBOCYTE; TREATMENT OUTCOME;

EID: 0030608116     PISSN: 01651781     EISSN: None     Source Type: Journal    
DOI: 10.1016/0165-1781(96)02862-4     Document Type: Article

References (45)

1. Abbate, R. and Boddi, M. (1987) Which test(s) for platelet aggregation? In: Born, G.V.R. and Neri Serneri, G.G. (Eds.), Antiplatelet Therapy: Twenty Years' Experience. Excerpta Medica, Amsterdam, pp. 91-102.
2. Andreasen, N.C. (1982) Negative symptoms in schizophrenia: Definition and reliability. Arch Gen Psychiatry 39, 784-794.
3. Arora, R.C. and Meltzer, H.Y. (1994) Effect of clozapine treatment on serotonin-2-receptor binding in the blood platelets of schizophrenic patients. Neuropsychopharmacology 10, 109-114.
4. Ashcroft, G.W., Crawford, T.B.B., Eccleston, D., Sharman, D.F., MacDougall, E.G., Stanton, J.B. and Binns, J.K. (1966) 5-Hydroxyindole compounds in the cerebrospinal fluid of patients with psychiatric or neurological disease. Lancet 11, 1049-1052.
5. Bevan, J. and Heptinstall, S. (1983) Effects of ketanserin and mepyramine on platelet aggregation and on the uptake of 5-hydroxytryptamine into platelets. Thromb Res 30, 415-423.
6. Bowers, M.B. (1973) 5-Hydroxyindole acetic acid (5-HIAA) and homovanillic acid (HVA) following protencid in acute psychiatric patients treated with phenothiazines. Psychopharmacology 28, 309-318.
7. Bunney, W.E. and Hamburg, D.A. (1963) Methods for reliable longitudinal observation of behavior. Arch Gen Psychiatry 19, 280-294.
8. De Clerck, F. (1990) The role of serotonin in thrombogenesis. Clin Physiol Biochem 8 (Suppl. 3), 40-49.
9. 2-receptor sites in the activation of cat platelets. Thromb Res 33, 305-321.
10. DeLisi, L.E., Neckers, L.M., Weinberger, D.R. and Wyatt, R. (1981) Increased whole blood serotonin concentrations in chronic schizophrenic patients. Arch Gen Psychiatry 38, 647-650.
11. Domino, E.F. and Krause, R.R. (1974) Free and bound serum tryptophan in drug-free normal controls and chronic schizophrenic patients. Biol Psychiatry 8, 265-279.
12. Eddington, N.D. and Young, D. (1988) Sensitive electrochemical high-performance liquid chromatography assay for the simultaneous determination of haloperidol and reduced haloperidol. J Pharmacol Sci 77, 541-543.
13. Endicott, J. and Spitzer, R.L. (1978) A diagnostic interview: the Schedule for Affective Disorders and Schizophrenia. Arch Gen Psychiatry 35, 837-844.
14. Essali, M.A., Das, I., de Belleroche, J. and Hirsch, S.R. (1990) The platelet polyphosphoinositide system in schizophrenia: The effect of neuroleptic treatment. Biol Psychiatry 28, 475-487.
15. Freedman, D., Belendiuk, K., Belendiuk, G. and Crayton, J. (1981) Blood tryptophan metabolism in chronic schizophrenics. Arch Gen Psychiatry 38, 655-659.
16. Garelis, E., Gillin, J.C., Wyatt, R. and Neff, N. (1975) Elevated blood serotonin concentration in unmedicated chronic schizophrenic patients. Am J Psychiatry 132, 184-186.
17. Gillin, J.C., Kaplan, J.A. and Wyatt, R.J. (1976) Clinical effects of tryptophan in chronic schizophrenic patients. Biol Psychiatry 11, 635-639.
18. Hathaway, S.R. and McKinley, J.C. (1970) Minnesota Multiphasic Personality Inventory. University of Minnesota Press, Minneapolis.
19. Jackman, H., Luchins, D. and Meltzer, H.Y. (1983) Platelet serotonin levels in schizophrenia: Relationship to race and psychopathology. Biol Psychiatry 18, 887-902.
20. Joseph, M., Owen, F., Baker, H. and Bourne, R. (1977) Platelet serotonin concentration and monoamine oxidase activity in unmedicated chronic schizophrenic and schizoaffective patients. Psychol Med 7, 159-162.
21. Kaiya, H., Nishida, A., Imai, A., Nakashima, S.N. and Nozawa, Y. (1989) Accumulation of diacylglycerol in platelet phosphoinositide turnover in schizophrenia: A biological marker of good prognosis? Biol Psychiatry 26, 669-676.
22. Kolakowska, T. and Molyneux, S.G. (1987) Platelet serotonin concentration in schizophrenic patients. Am J Psychiatry 144, 232-234.
23. Lechin, F., Coll-Garcia, F., Vander Dija, A., Bentolila, A., Pena, F. and Rivar, C. (1979) The effects of dopaminergic blocking agents on the glucose tolerance level in 6 humans and 6 dogs. Experientia 35, 886-887.
24. Lesch, K.-P., Wolozin, D.L., Murphy, D.L. and Riederer, P. (1993) Primary structure of the human platelet serotonin uptake site: Identity with the brain serotonin transporter. J Neurochem 60, 2319-2322.
25. 2 receptors, roles and regulation. Ann N Y Acad Sci 600, 183-193.
26. Manowitz, P., Gilmour, D.G. and Racevskis, J. (1973) Low plasma tryptophan levels in recently hospitalized schizophrenics. Biol Psychiatry 6, 109-118.
27. McBride, P.A., Anderson, G.M., Hertzig, M., Sweeney, J.A., Kream, J., Cohen, D.J. and Mann, J.J. (1989) Serotonergic responsivity in male young adults with autistic disorder. Arch Gen Psychiatry 46, 213-221.
28. Meltzer, H.Y. (1989) Clinical studies on the mechanism of action of clozapine: The dopamine-serotonin hypothesis of schizophrenia. Psychopharmacology 99, S18-S27.
29. Meltzer, H.Y. (1991) The mechanism of action of novel antipsychotic drugs. Schizophr Bull 17, 263-287.
30. Muck-Seler, D., Jakovljevie, M. and Deanovie, Z. (1988) Time course of schizophrenia and platelet 5-HT level. Biol Psychiatry 23, 243-251.
31. Opstvedt, A., Rongved, S., Arasaether, N., Lillenhaug, R. and Holmsen, H. (1986) Differential effects of chlorpromazine on secretion, protein phosphorylation and phosphoinositide metabolism in stimulated platelets. Biochem J 238, 159-166.
32. 2 receptor binding characteristics in the individual and the putative regulation by serotonin. J Neural Transm 93, 27-35.
33. Overall, J.E. and Gorham, D.R. (1962) The Brief Psychiatric Rating Scale. Psychol Rep 10, 799-812.
34. Riess, H., Braun, G., Brehm, G. and Hiller, E. (1986) Critical evaluation of platelet aggregation in whole human blood. Am J Clin Pathol 85, 50-56.
35. 2-adrenergic receptor populations on phosphoinositide hydrolysis. Life Sci 50, 169-180.
36. Sathiropas, P., Marbet, G.A., Sahaphong, S. and Duckert, F. (1988) Detection of small inhibitory effects of acetylsalicylic acid (ASA) by platelet impedance aggregometry in whole blood. Thromb Res 51, 55-62.
37. Spitzer, R.L., Williams, J.B.W., Gibbon, M. and First, M.B. (1989) Structured Clinical Interview for DSM-III-R - Patient Version (SCID-P). New York State Psychiatric Institute, New York.
38. Stahl, S.M., Wood, D.J., Mefford, I.N., Berger, P.A. and Ciaranello, R.D. (1983) Hyperserotoninemia and platelet serotonin uptake and release in schizophrenia and affective disorders. Am J Psychiatry 140, 26-30.
39. 32P-labelled polyphosphoinositide in human platelets. Biochem Biophys Res Comm 131, 370-377.
40. van Kammen, D.P., Peters, J., van Kammen, W.B., Nugent, A., Goetz, K.L., Yao, J. and Linnoila, M. (1989) Elevated CSF NE and relapse in schizophrenia. Biol Psychiatry 26, 178-188.
41. Wyatt, R.J., Vaughan, T., Galanter, M., Kaplan, J. and Green, R. (1972) Behavioral changes of chronic schizophrenic patients given L-5-hydroxytryptophan. Science 177, 1124-1126.
42. Yao, J.K. and van Kammen, D.P. (1994) Red blood cell membrane dynamics schizophrenia. I. Membrane fluidity. Schizophr Res 11, 209-216.
43. Yao, J.K., van Kammen, D.P. and Gurklis, J. (1994a) Red blood cell membrane dynamics in schizophrenia. III. Correlation of fatty acid abnormalities with clinical measures. Schizophr Res 13, 227-232.
44. Yao, J.K., van Kammen, D.P., Gurklis, J. and Peters, J.L. (1994b) Platelet aggregation and dense granule secretion in schizophrenia. Psychiatry Res 54, 13-24.
45. Yao, J.K., Yasaei, P. and van Kammen, D.P. (1992) Increased turnover of platelet phosphatidylinositol in schizophrenia. Prostaglandins, Leukotrienes & Essential Fatty Acids 46, 39-46.